We primarily investigated the additive anti-proliferative and anti-migratory effects of HMOX1 and PFKFB4 knockdown alone or in combination with temozolomide (TMZ) and doxorubicin in U87-MG Glioblastoma Cells. The gene discussed is PFKFB4; the disease is glioblastoma.